Header Logo

Connection

Eileen Martin to Male

Back to Details
This is a "connection" page, showing publications Eileen Martin has written about Male.
Eileen Martin
Connection Strength
1.577
Male
  1. Effects of sex and HIV serostatus on spatial navigational learning and memory among cocaine users. J Neurovirol. 2017 Dec; 23(6):855-863.
    View in: PubMed
    Score: 0.105
  2. Shift within age-groups of mumps incidence, hospitalizations and severe complications in a highly vaccinated population. Spain, 1998-2014. Vaccine. 2017 08 03; 35(34):4339-4345.
    View in: PubMed
    Score: 0.104
  3. Sex and HIV serostatus differences in decision making under risk among substance-dependent individuals. J Clin Exp Neuropsychol. 2016; 38(4):404-15.
    View in: PubMed
    Score: 0.093
  4. Delay discounting is greater among drug users seropositive for hepatitis C but not HIV. Neuropsychology. 2015 Nov; 29(6):926-32.
    View in: PubMed
    Score: 0.089
  5. HIV+ men and women show different performance patterns on procedural learning tasks. J Clin Exp Neuropsychol. 2011 Jan; 33(1):112-20.
    View in: PubMed
    Score: 0.064
  6. Iowa Gambling Task performance and emotional distress interact to predict risky sexual behavior in individuals with dual substance and HIV diagnoses. J Clin Exp Neuropsychol. 2010 Dec; 32(10):1110-21.
    View in: PubMed
    Score: 0.063
  7. Influence of procedural learning on Iowa Gambling Task performance among HIV+ individuals with history of substance dependence. Arch Clin Neuropsychol. 2010 Feb; 25(1):28-38.
    View in: PubMed
    Score: 0.061
  8. HIV, cognition and women. Neuropsychol Rev. 2009 Jun; 19(2):204-14.
    View in: PubMed
    Score: 0.059
  9. Auditory working memory in HIV-1 infection. J Int Neuropsychol Soc. 2001 Jan; 7(1):20-6.
    View in: PubMed
    Score: 0.033
  10. Brain structural correlates of trajectories to cognitive impairment in men with and without HIV disease. Brain Imaging Behav. 2020 Jun; 14(3):821-829.
    View in: PubMed
    Score: 0.032
  11. Thought disorder in schizophrenia and mania: impaired context. Schizophr Bull. 2000; 26(4):879-91.
    View in: PubMed
    Score: 0.031
  12. Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report. J Clin Exp Neuropsychol. 1999 Oct; 21(5):730-5.
    View in: PubMed
    Score: 0.030
  13. Neuropsychological changes in efavirenz switch regimens. AIDS. 2019 07 01; 33(8):1307-1314.
    View in: PubMed
    Score: 0.030
  14. Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study. Neurology. 2019 07 16; 93(3):e261-e271.
    View in: PubMed
    Score: 0.030
  15. Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men. Subst Use Misuse. 2019; 54(4):525-537.
    View in: PubMed
    Score: 0.029
  16. Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection. AIDS. 2018 08 24; 32(13):1849-1860.
    View in: PubMed
    Score: 0.028
  17. HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition. AIDS. 2018 08 24; 32(13):1803-1810.
    View in: PubMed
    Score: 0.028
  18. Intraindividual variability in neurocognitive performance: No influence due to HIV status or self-reported effort. J Clin Exp Neuropsychol. 2018 12; 40(10):1044-1049.
    View in: PubMed
    Score: 0.028
  19. Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study. AIDS. 2018 07 31; 32(12):1679-1688.
    View in: PubMed
    Score: 0.028
  20. Information processing and antiretroviral therapy in HIV-1 infection. J Int Neuropsychol Soc. 1998 Jul; 4(4):329-35.
    View in: PubMed
    Score: 0.028
  21. Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study. Lancet HIV. 2017 09; 4(9):e411-e422.
    View in: PubMed
    Score: 0.026
  22. Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):203-210.
    View in: PubMed
    Score: 0.026
  23. Trajectories of Marijuana Use among HIV-seropositive and HIV-seronegative MSM in the Multicenter AIDS Cohort Study (MACS), 1984-2013. AIDS Behav. 2017 Apr; 21(4):1091-1104.
    View in: PubMed
    Score: 0.025
  24. Transcriptome analyses identify key cellular factors associated with HIV-1-associated neuropathogenesis in infected men. AIDS. 2017 03 13; 31(5):623-633.
    View in: PubMed
    Score: 0.025
  25. Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984-2013. Am J Drug Alcohol Abuse. 2017 09; 43(5):556-566.
    View in: PubMed
    Score: 0.025
  26. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 2016 Jan 26; 86(4):334-40.
    View in: PubMed
    Score: 0.023
  27. Delayed recognition memory span in HIV-1 infection. J Int Neuropsychol Soc. 1995 Nov; 1(6):575-80.
    View in: PubMed
    Score: 0.023
  28. Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study. AIDS. 2015 Mar 27; 29(6):713-21.
    View in: PubMed
    Score: 0.022
  29. Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men. Antivir Ther. 2015; 20(2):235-44.
    View in: PubMed
    Score: 0.022
  30. No association between Apoe4 alleles, HIV infection, age, neuropsychological outcome, or death. J Neurovirol. 2015 Feb; 21(1):24-31.
    View in: PubMed
    Score: 0.022
  31. Cohort Profile: Recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study. Int J Epidemiol. 2015 Oct; 44(5):1506-16.
    View in: PubMed
    Score: 0.021
  32. The longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning. J Neurovirol. 2014 Jun; 20(3):243-57.
    View in: PubMed
    Score: 0.021
  33. Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men. Neurology. 2013 Dec 10; 81(24):2094-102.
    View in: PubMed
    Score: 0.020
  34. Speed of memory scanning is not affected in early HIV-1 infection. J Clin Exp Neuropsychol. 1993 Mar; 15(2):311-20.
    View in: PubMed
    Score: 0.019
  35. Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study. J Neurovirol. 2013 Feb; 19(1):24-31.
    View in: PubMed
    Score: 0.019
  36. Performance of patients with early HIV-1 infection on the Stroop Task. J Clin Exp Neuropsychol. 1992 Sep; 14(5):857-68.
    View in: PubMed
    Score: 0.019
  37. Spatial attention in HIV-1 infection: a preliminary report. J Neuropsychiatry Clin Neurosci. 1992; 4(3):288-93.
    View in: PubMed
    Score: 0.018
  38. Decision-making speed in HIV-1 infection: a preliminary report. AIDS. 1992 Jan; 6(1):109-13.
    View in: PubMed
    Score: 0.018
  39. Platelet decline as a predictor of brain injury in HIV infection. J Neurovirol. 2011 Oct; 17(5):487-95.
    View in: PubMed
    Score: 0.017
  40. Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav. 2011 Jun; 5(2):77-85.
    View in: PubMed
    Score: 0.017
  41. Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology. 2012 Feb; 54(2):113-21.
    View in: PubMed
    Score: 0.017
  42. Psychopathic heroin addicts are not uniformly impaired across neurocognitive domains of impulsivity. Drug Alcohol Depend. 2011 Apr 01; 114(2-3):194-200.
    View in: PubMed
    Score: 0.016
  43. White matter anisotropy and depression symptoms in patients with HIV. J Neuropsychiatry Clin Neurosci. 2008; 20(4):458-65.
    View in: PubMed
    Score: 0.013
  44. HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study. J Acquir Immune Defic Syndr. 2007 Dec 15; 46(5):564-73.
    View in: PubMed
    Score: 0.013
  45. Cortical biopsy results in Alzheimer's disease: correlation with cognitive deficits. Neurology. 1987 Jul; 37(7):1201-4.
    View in: PubMed
    Score: 0.013
  46. Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol. 2003 Jun; 114(6):1125-32.
    View in: PubMed
    Score: 0.010
  47. Communication effectiveness in psychosis-prone college students. J Abnorm Psychol. 1982 Dec; 91(6):420-5.
    View in: PubMed
    Score: 0.009
  48. Immune-specific immunoglobulin G-mediated enhancement of human immunodeficiency virus-induced IFN-alpha production. J Interferon Cytokine Res. 2002 Dec; 22(12):1201-8.
    View in: PubMed
    Score: 0.009
  49. The relationship between positive symptoms and instrumental work functioning in schizophrenia: a 10 year follow-up study. Schizophr Res. 2002 Jul 01; 56(1-2):95-103.
    View in: PubMed
    Score: 0.009
  50. Verbal working memory in HIV-seropositive drug users. J Int Neuropsychol Soc. 2000 Jul; 6(5):548-55.
    View in: PubMed
    Score: 0.008
  51. Postural reflexes in patients with HIV-1 infection. Electroencephalogr Clin Neurophysiol. 1998 Oct; 109(5):402-8.
    View in: PubMed
    Score: 0.007
  52. Working memory deficits in HIV-seropositive drug users. J Int Neuropsychol Soc. 1997 Sep; 3(5):451-6.
    View in: PubMed
    Score: 0.007
  53. Postoperative cognitive and single photon emission computed tomography assessment of patients with resection of perioperative high-risk arteriovenous malformations. Neurosurgery. 1995 Mar; 36(3):447-57; discussion 457-8.
    View in: PubMed
    Score: 0.005
  54. Successful methylphenidate treatment of apathy after subcortical infarcts. J Neuropsychiatry Clin Neurosci. 1995; 7(4):502-4.
    View in: PubMed
    Score: 0.005
  55. Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain. 1992 Apr; 115 ( Pt 2):521-37.
    View in: PubMed
    Score: 0.004
  56. Intraventricular bethanechol infusion for Alzheimer's disease: results of double-blind and escalating-dose trials. Neurology. 1988 Feb; 38(2):219-22.
    View in: PubMed
    Score: 0.003
  57. Treatments for cigarette smoking: an evaluation of the contributions of aversion and counseling procedures. Behav Res Ther. 1986; 24(4):437-52.
    View in: PubMed
    Score: 0.003
  58. Drug signals enhance morphine tolerance development in hypophysectomized rats. Psychopharmacology (Berl). 1983; 79(1):84-5.
    View in: PubMed
    Score: 0.002
  59. Aversive smoking therapies: a conditioning analysis of therapeutic effectiveness. Behav Res Ther. 1983; 21(6):595-611.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.